148 related articles for article (PubMed ID: 2412918)
21. Axonal transport and nerve conduction and their relation to nerve polyol and myo-inositol levels in spontaneously diabetic BB/D rats.
Mayer JH; Herberg L; Tomlinson DR
Neurochem Pathol; 1984-1985 Winter; 2(4):285-93. PubMed ID: 6085698
[TBL] [Abstract][Full Text] [Related]
22. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
Poulsom R; Mirrlees DJ; Earl DC; Heath H
Exp Eye Res; 1983 May; 36(5):751-60. PubMed ID: 6406254
[TBL] [Abstract][Full Text] [Related]
23. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil.
Kofo-Abayomi A; Lucas PD
J Pharm Pharmacol; 1987 Dec; 39(12):1019-21. PubMed ID: 2894428
[TBL] [Abstract][Full Text] [Related]
24. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
Price DE; Airey CM; Alani SM; Wales JK
Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
[TBL] [Abstract][Full Text] [Related]
25. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
26. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
[TBL] [Abstract][Full Text] [Related]
27. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
28. Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes?
Willars GB; Lambourne JE; Tomlinson DR
Diabetes; 1987 Dec; 36(12):1425-31. PubMed ID: 3678622
[TBL] [Abstract][Full Text] [Related]
29. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
Lee PG; Hohman TC; Cai F; Regalia J; Helke CJ
Exp Neurol; 2001 Jul; 170(1):149-61. PubMed ID: 11421592
[TBL] [Abstract][Full Text] [Related]
30. Pressure-induced inhibition of fast axonal transport of proteins in the rabbit vagus nerve in galactose neuropathy: prevention by an aldose reductase inhibitor.
McLean WG
Diabetologia; 1988 Jul; 31(7):443-8. PubMed ID: 2464514
[TBL] [Abstract][Full Text] [Related]
31. Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats.
Gillon KR; Hawthorne JN
Biochem J; 1983 Mar; 210(3):775-81. PubMed ID: 6870806
[TBL] [Abstract][Full Text] [Related]
32. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
[TBL] [Abstract][Full Text] [Related]
33. Aldose reductase activity and myo-inositol levels in sciatic nerve and dorsal root ganglia of the diabetic mutant mouse [C57/BL/Ks (db/db)].
Llewelyn JG; Thomas PK; Mirrlees DJ
Metabolism; 1991 Oct; 40(10):1084-7. PubMed ID: 1943734
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
35. Axonal transport of choline acetyltransferase and 6-phosphofructokinase activities in genetically diabetic mice.
Calcutt NA; Willars GB; Tomlinson DR
Muscle Nerve; 1988 Dec; 11(12):1206-10. PubMed ID: 2467203
[TBL] [Abstract][Full Text] [Related]
36. Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition.
Diemel LT; Stevens EJ; Willars GB; Tomlinson DR
Neurosci Lett; 1992 Mar; 137(2):253-6. PubMed ID: 1374869
[TBL] [Abstract][Full Text] [Related]
37. Impaired axonal transport of opiate and muscarinic receptors in streptozocin-diabetic rats.
Laduron PM; Janssen PF
Brain Res; 1986 Aug; 380(2):359-62. PubMed ID: 2428426
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy.
Bhoyrul S; Sharma AK; Stribling D; Mirrlees DD; Peterson RG; Farber MO; Thomas PK
J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441
[TBL] [Abstract][Full Text] [Related]
39. Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity.
Calcutt NA; Tomlinson DR; Willars GB
J Neurochem; 1988 May; 50(5):1478-83. PubMed ID: 2452237
[TBL] [Abstract][Full Text] [Related]
40. Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor.
Ekström AR; Tomlinson DR
J Neurol Sci; 1989 Nov; 93(2-3):231-7. PubMed ID: 2531788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
